Showing results (1-10 of 180) with videos related to
Sort By:
Pageof 18
Current Pharmaceutical Biotechnology|February 18, 2004
Combinatorial protein biochemistry for therapeutics and proteomicsDavid Lowe, Lutz JermutusIdrugs : the Investigational Drugs Journal|November 25, 2004
Phage Display Technologies - SMi Conference. 23-24 January 2002, London, UKLutz JermutusDrug Discovery Today|September 12, 2015
Challenges and opportunities for non-antibody scaffold drugsRodrigo Vazquez-Lombardi, Tri Giang Phan, Carsten Zimmermann, et al.Briefings in Functional Genomics & Proteomics|July 9, 2004
Concepts in antibody phage displaySara Carmen, Lutz JermutusCurrent Opinion in Drug Discovery & Development|March 29, 2006
Exploiting directed evolution for the discovery of biologicalsJulie Douthwaite, Lutz JermutusDrug Discovery Today|September 10, 2003
Current methods for the generation of human antibodies for the treatment of autoimmune diseasesJane Osbourn, Lutz Jermutus, Alex DuncanNature Protocols|February 4, 2012
Expression of high-affinity human antibody fragments in bacteriaRomain Rouet, David Lowe, Kip Dudgeon, et al.Trends in Biotechnology|September 27, 2006
Harnessing phage and ribosome display for antibody optimisationPatrick Dufner, Lutz Jermutus, Ralph R MinterBiochemical Society Transactions|September 8, 2021
The role of pro-domains in human growth factors and cytokinesMatthew Ratcliff, Richard Xu Zhou, Lutz Jermutus, et al.Protein Engineering, Design & Selection : PEDS|April 16, 2008
In vitro DNA recombination by L-Shuffling during ribosome display affinity maturation of an anti-Fas antibody increases the population of improved variantsMatthieu Chodorge, Laurent Fourage, Gilles Ravot, et al.Pageof 18